Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous paracetamol for perioperative pain control in radical prostatectomy
IRCT20160602028225N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetaminophen in prostate cancer (PCa), sponsored by Iran University of Medical Sciences. Primary endpoints: Severity of pain, Dose of opioids and 1 more. Started May 2020; status: completed.
02
Drugs
acetaminophen
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on IRCT20160602028225N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160602028225N2.